MedTrace Logo

Sleep Disturbances as a Risk Factor in Chronic Kidney Disease

NCT00817427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-09-05

No results posted yet for this study

Summary

This study is designed to determine if either short night time sleep or poor night time sleep could be a risk factor for increasing the rate at which kidney function deteriorates in persons with mild to moderate kidney disease.

Conditions

Interventions

OTHER

Controls Short sleep

Healthy control subject's bedtime will be decreased by 2 hours/night with acoustic sleep disruption

OTHER

CKD- sleep extension

Sleep will be increased by 2 hours each night for 3 nights

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Eve Van Cauter, PhD · University of Chicago

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2011-06-30
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00817427 on ClinicalTrials.gov